Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1993-10-07
1995-10-17
Hutzell, Paula K.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
53038822, 5303888, 4351722, 435 7021, C12N 520, C07K 1628, C07K 1630
Patent
active
054590612
ABSTRACT:
Hybridomas producing monoclonal antibodies that specifically bind to the human EGF receptor and compete with EGF for binding to the EGF receptor are described. The subject monoclonal antibodies bind to an epitope located between residues Ala-351 and Asp-364 of the EGF receptor, which is not denatured by boiling, treatment with detergent or treatment with a reducing agent.
REFERENCES:
Mendelsohn et al. Cellular & Mol. Biol. of Tumors & Pot'l. Clin. Applications pp. 307-312. 1988.
Kudlow et al. J Biol. Chem. 259:11895-11900, 1984.
Parsons-Chandler et al. J Biol Chem 260:3360-3367, 1987.
Wu et al. J. Biol. Chem. 264:17469-17454 15 Oct. 1989.
Lerner, Nature 299:592 1982.
Ullrich et al. Nature 309:418 1984.
Appel et al. J. Immunology 144:976-983, 1990.
Dayhoff et al. "Atlas of Protein Sequence and Structure" vol. 5:89-99, 1972.
Sato J. Denry
Wang Lihua
Wu Dianging
Hutzell Paula K.
W. Alton Jones Cell Science Center, Inc.
LandOfFree
Hybridomas producing monoclonal antibodies which specifically bi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybridomas producing monoclonal antibodies which specifically bi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridomas producing monoclonal antibodies which specifically bi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-596691